Sol-Gel Technologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.

About SLGL

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.

CEO

Alon Seri-Levy

CEOAlon Seri-Levy

Employees

Employees36

Headquarters

Ness Ziona, Tel Aviv

HeadquartersNess Ziona, Tel Aviv

Founded

1997

Founded1997

Employees

Employees36

SLGL Key Statistics

Market cap

26.75M

Market cap26.75M

Price-Earnings ratio

-0.89

Price-Earnings ratio-0.89

Dividend yield

—

Dividend yield—

Average volume

32.61K

Average volume32.61K

High today

$0.9999

High today$0.9999

Low today

$0.8946

Low today$0.8946

Open price

$0.943

Open price$0.943

Volume

10.21K

Volume10.21K

52 Week high

$4.20

52 Week high$4.20

52 Week low

$0.79

52 Week low$0.79

Sol-Gel Technologies

Why Robinhood?

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. Show more

SLGL Key Statistics

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.